Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2016 | Research article

Antibacterial in vitro effects of preparations from Anthroposophical Medicine

Authors: Eva Roser, Carsten Gründemann, Inge Engels, Roman Huber

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

Medications from Anthroposophical Medicine (AM) are clinically used for the treatment of infections within a whole medical system but have not yet been evaluated regarding antibacterial effects. The aims of this study was to investigate antibacterial activity of AM medications in cell culture.

Methods

Screening of AM drug registers for preparations used to treat any kind of infection and being available in dilutions ≤ D2 and without alcoholic content. Selected medications were screened for antimicrobial activity against Bacillus subtilis, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa using the agar diffusion method. For antimicrobial active preparations growth kinetics (drop plate method) and minimal inhibitory concentrations (MIC, macrodilution method) were determined.

Results

Thirty-three preparations matched the selection criteria and were chosen for own experiments. One of them (Berberis Decoctum D2) exhibited bactericidal activities against Bacillus subtilis and Staphylococcus aureus, including methicillin resistant strains. The MIC could be determined as 5 mg/ml. The effects could be related to the content of berberine in the extract. No activity towards gram-negative bacteria was found. The other tested extracts had no antibacterial effects.

Conclusion

Berberis Decoctum D2 which is used in AM to treat infections exhibits bactericidal effects on Staphylococcus aureus, including methicillin resistant strains.
Literature
1.
go back to reference Fauci AS, NIAID Tuberculosis Working Group. Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research. J Infect Dis. 2008;197:1493–8.CrossRefPubMed Fauci AS, NIAID Tuberculosis Working Group. Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research. J Infect Dis. 2008;197:1493–8.CrossRefPubMed
2.
go back to reference Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:μ20–32.CrossRef Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:μ20–32.CrossRef
4.
go back to reference Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J. and Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46:155–64.CrossRef Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J. and Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46:155–64.CrossRef
5.
go back to reference Abreu AC, McBain AJ, Simões M. Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep. 2012;29:1007–21.CrossRefPubMed Abreu AC, McBain AJ, Simões M. Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep. 2012;29:1007–21.CrossRefPubMed
6.
go back to reference Ríos JL, Recio MC. Medicinal plants and antimicrobial activity. J Ethnopharmacol. 2005;100:80–4.CrossRefPubMed Ríos JL, Recio MC. Medicinal plants and antimicrobial activity. J Ethnopharmacol. 2005;100:80–4.CrossRefPubMed
7.
go back to reference Han Y, Lee J-H. Berberine synergy with amphotericin B against disseminated candidiasis in mice. Biol Pharm Bull. 2005;28:541–44.CrossRefPubMed Han Y, Lee J-H. Berberine synergy with amphotericin B against disseminated candidiasis in mice. Biol Pharm Bull. 2005;28:541–44.CrossRefPubMed
8.
go back to reference Jayaraman P, Sakharkar MK, Lim CS, Tang TH, Sakharkar KR. Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. Int J Biol Sci. 2010;6:556–68.CrossRefPubMedPubMedCentral Jayaraman P, Sakharkar MK, Lim CS, Tang TH, Sakharkar KR. Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. Int J Biol Sci. 2010;6:556–68.CrossRefPubMedPubMedCentral
9.
go back to reference Oluwatuyi M, Kaatz GW, Gibbons S. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry. 2004;65:3249–54.CrossRefPubMed Oluwatuyi M, Kaatz GW, Gibbons S. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry. 2004;65:3249–54.CrossRefPubMed
10.
go back to reference Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev. 2013;10:CD006323. Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev. 2013;10:CD006323.
11.
go back to reference Albrecht U, Goos KH, Schneider B. A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections. Curr Med Res Opin. 2007;23:2415–22.CrossRefPubMed Albrecht U, Goos KH, Schneider B. A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections. Curr Med Res Opin. 2007;23:2415–22.CrossRefPubMed
12.
go back to reference Conrad A, Biehler D, Nobis T, Richter H, Engels I, Biehler K, Frank U. Broad spectrum antibacterial activity of a mixture of isothiocyanates from nasturtium (Tropaeoli majoris herba) and horseradish (Armoraciae rusticanae radix). Drug Res. 2013;63:65–8.CrossRef Conrad A, Biehler D, Nobis T, Richter H, Engels I, Biehler K, Frank U. Broad spectrum antibacterial activity of a mixture of isothiocyanates from nasturtium (Tropaeoli majoris herba) and horseradish (Armoraciae rusticanae radix). Drug Res. 2013;63:65–8.CrossRef
13.
go back to reference Fintelmann V, Albrecht U, Schmitz G, Schnitker J. Efficacy and safety of a combination herbal medicinal product containing Tropaeoli majoris herba and Armoraciae rusticanae radix for the prophylactic treatment of patients with respiratory tract diseases: a randomised, prospective, double-blind, placebo-controlled phase III trial. Curr Med Res Opin. 2012;28:1799–807.CrossRefPubMed Fintelmann V, Albrecht U, Schmitz G, Schnitker J. Efficacy and safety of a combination herbal medicinal product containing Tropaeoli majoris herba and Armoraciae rusticanae radix for the prophylactic treatment of patients with respiratory tract diseases: a randomised, prospective, double-blind, placebo-controlled phase III trial. Curr Med Res Opin. 2012;28:1799–807.CrossRefPubMed
14.
go back to reference Maranduba CM, De Castro SBR, de Souza GT, Rossato C, da Guia FC, Valente MAS, et al. Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. J Immunol Res. 2015;2015:931574.CrossRefPubMedPubMedCentral Maranduba CM, De Castro SBR, de Souza GT, Rossato C, da Guia FC, Valente MAS, et al. Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. J Immunol Res. 2015;2015:931574.CrossRefPubMedPubMedCentral
15.
go back to reference Tilg H. Obesity, metabolic syndrome, and microbiota: multiple interactions. J Clin Gastroenterol. 2010;44 Suppl 1:S16–8.CrossRefPubMed Tilg H. Obesity, metabolic syndrome, and microbiota: multiple interactions. J Clin Gastroenterol. 2010;44 Suppl 1:S16–8.CrossRefPubMed
16.
go back to reference Wilson MT, Hamilos DL. The Nasal and Sinus Microbiome in Health and Disease. Curr Allergy Asthma Rep. 2014;14. Wilson MT, Hamilos DL. The Nasal and Sinus Microbiome in Health and Disease. Curr Allergy Asthma Rep. 2014;14.
17.
go back to reference Bosca-Watts MM, Tosca J, Anton R, Mora M, Minguez M, Mora F. Pathogenesis of Crohn’s disease: Bug or no bug. World J Gastrointest Pathophysiol. 2015;6:1–12.CrossRefPubMedPubMedCentral Bosca-Watts MM, Tosca J, Anton R, Mora M, Minguez M, Mora F. Pathogenesis of Crohn’s disease: Bug or no bug. World J Gastrointest Pathophysiol. 2015;6:1–12.CrossRefPubMedPubMedCentral
19.
go back to reference Zwiauer J. Anthroposophisch erweiterte Medizin. Ch.Möllmann, Jear: 2013. Zwiauer J. Anthroposophisch erweiterte Medizin. Ch.Möllmann, Jear: 2013.
20.
go back to reference Schramm H. Heilmittel der anthroposophischen Medizin Grundlagen Arzneimittelporträts Anwendung. München: Urban&Fischer; 2009. Schramm H. Heilmittel der anthroposophischen Medizin Grundlagen Arzneimittelporträts Anwendung. München: Urban&Fischer; 2009.
21.
go back to reference WALA Arzneimittelverzeichnis (drug register). WALA Heilmittel GmbH Bad Boll, Germany, 34th edition 2013/2014. WALA Arzneimittelverzeichnis (drug register). WALA Heilmittel GmbH Bad Boll, Germany, 34th edition 2013/2014.
22.
go back to reference Weleda Arzneimittelverzeichnis (drug register), Weleda AG Schwäbisch Gmünd, Germany, 27th edition 2015. Weleda Arzneimittelverzeichnis (drug register), Weleda AG Schwäbisch Gmünd, Germany, 27th edition 2015.
23.
go back to reference Janssen AM, Scheffer JJ, Baerheim-Svendsen A. Antimicrobial activity of essential oils: a 1976-1986 literature review. Aspects of the test methods. Planta Med. 1986;53:395–98.CrossRef Janssen AM, Scheffer JJ, Baerheim-Svendsen A. Antimicrobial activity of essential oils: a 1976-1986 literature review. Aspects of the test methods. Planta Med. 1986;53:395–98.CrossRef
24.
go back to reference Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008;22:999–1012.CrossRefPubMed Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008;22:999–1012.CrossRefPubMed
25.
go back to reference Ahn YJ, Park SJ, Lee SG, Shin SC, Choi DH. Cordycepin: selective growth inhibitor derived from liquid culture of Cordyceps militaris against Clostridium spp. J Agric Food Chem. 2000;48:2744–48.CrossRefPubMed Ahn YJ, Park SJ, Lee SG, Shin SC, Choi DH. Cordycepin: selective growth inhibitor derived from liquid culture of Cordyceps militaris against Clostridium spp. J Agric Food Chem. 2000;48:2744–48.CrossRefPubMed
26.
go back to reference Diarra MS, Block G, Rempel H, Oomah BD, Harrison J, McCallum J, Boulanger S, Brouillette É, Gattuso M, Malouin F. In vitro and in vivo antibacterial activities of cranberry press cake extracts alone or in combination with β-lactams against Staphylococcus aureus. BMC Complement Altern Med. 2013;13:90.CrossRefPubMedPubMedCentral Diarra MS, Block G, Rempel H, Oomah BD, Harrison J, McCallum J, Boulanger S, Brouillette É, Gattuso M, Malouin F. In vitro and in vivo antibacterial activities of cranberry press cake extracts alone or in combination with β-lactams against Staphylococcus aureus. BMC Complement Altern Med. 2013;13:90.CrossRefPubMedPubMedCentral
27.
go back to reference Freitas E, Aires A, de Santos Rosa EA, Saavedra MJ. Antibacterial activity and synergistic effect between watercress extracts, 2-phenylethyl isothiocyanate and antibiotics against 11 isolates of Escherichia coli from clinical and animal source. Lett Appl Microbiol. 2013;57:266–73.PubMed Freitas E, Aires A, de Santos Rosa EA, Saavedra MJ. Antibacterial activity and synergistic effect between watercress extracts, 2-phenylethyl isothiocyanate and antibiotics against 11 isolates of Escherichia coli from clinical and animal source. Lett Appl Microbiol. 2013;57:266–73.PubMed
Metadata
Title
Antibacterial in vitro effects of preparations from Anthroposophical Medicine
Authors
Eva Roser
Carsten Gründemann
Inge Engels
Roman Huber
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-016-1350-3

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue